The paradigm shift from polycythemia to anemia in COPD: the critical role of the renin–angiotensin system inhibitors

References

• Divo MJ, Celli BR, Poblador-Plou B, et al. Chronic Obstructive Pulmonary Disease (COPD) as a disease of early aging: evidence from the EpiChron Cohort. PLoS ONE. 2018;13(2):e0193143.
   PubMed Web of Science ®Google Scholar
• Cote C, Zilberberg MD, Mody SH, et al. Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J. 2007;29(5):923–929.
   PubMed Web of Science ®Google Scholar
• Chambellain Α, Chailleux Ε, Similowski Th, for the ANTADIR Observatory Group. Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy. CHEST. 2005;128(3):1201–1208.
   PubMed Web of Science ®Google Scholar
• John M, Lange A, Hoernig S, et al. Prevalence of anemia in chronic obstructive pulmonary disease: comparison to other chronic diseases. Int J Cardiol. 2006;111(3):365–370.
   PubMed Web of Science ®Google Scholar
• Portillo K, Belda J, Antón P. High frequency of anemia in COPD patients admitted in a tertiary hospital. Rev Clin Esp. 2007;207(8):383–387.
   PubMed Web of Science ®Google Scholar
• Parveen S, Rangreze I, Ahmad SN, et al. Prevalence of anemia in patients with COPD and its potential impact on morbidity of COPD patients. Int J Clin Med. 2014;5(8):452–458.
   Google Scholar
• Martinez-Rivera C, Portillo K, Muñoz-Ferrer A, et al. Anemia is a mortality predictor in hospitalized patients for COPD exacerbation. COPD. 2012;9(3):243–250.
   PubMedGoogle Scholar
• Rahimi-Rad MH, Sadighi T, Rabieepour M, et al. Prevalence of anemia and its impact on mortality in patients with acute exacerbation of chronic obstructive pulmonary disease in a developing country setting. Pneumologia. 2015;64(3):27–30.
   PubMedGoogle Scholar
• Silverberg DS, Mor R, Weu MT, et al. Anemia and iron deficiency in COPD patients: prevalence and the effects of correction of the anemia with erythropoiesis stimulating agents and intravenous iron. BMC Pulm Med. 2014;14(1):24.
   PubMedGoogle Scholar
• John M, Hoernig S, Doehner W, et al. Anemia and inflammation in COPD. Chest. 2005;127(3):825–829.
   PubMed Web of Science ®Google Scholar
• Halpern MT, Zilberberg MD, Schmier JK, et al. Anemia, costs and mortality in chronic obstructive pulmonary disease. Cost Eff Resour Alloc. 2006;4(1):17.
   PubMedGoogle Scholar
• Krishnan G, Grant BJ, Muti PC, et al. Association between anemia and quality of life in a population sample of individuals with chronic obstructive pulmonary disease. BMC Pulm Med. 2006;6(1):23.
   PubMedGoogle Scholar
• Attaran D, Khajedalouee M, Ahmadi F, et al. Anemia in COPD patients and its relation to serum levels of erythropoietin. Tanaffos. 2009;8(2):11–16.
   Google Scholar
• Kollert F, Tippelt A, Müller C, et al. Hemoglobin levels above anemia thresholds are maximally predictive for long-term survival in COPD with chronic respiratory failure. Respir Care. 2013;58(7):1204–1212.
   PubMed Web of Science ®Google Scholar
• Rutten EP, Franssen FM, Spruit MA, et al. Anemia is associated with bone mineral density in chronic obstructive pulmonary disease. COPD. 2013;10(3):286–292.
   PubMedGoogle Scholar
• Casanova LC, Echave-Sustaeta JM, Luján RG, et al. Prevalence of anaemia associated with chronic obstructive pulmonary disease. Study Assoc Var Arch Bronconeumol. 2013;49. 383–387.
   PubMed Web of Science ®Google Scholar
• Boutou AK, Stanopoulos I, Pitsiou GG, et al. Anemia of chronic disease in chronic obstructive pulmonary disease: a case-control study of cardiopulmonary exercise responses. Respiration. 2011;82(3):237–245.
   PubMed Web of Science ®Google Scholar
• Schneckenpointner R, Jörres RA, Meidenbauer N, et al. The clinical significance of anaemia and disturbed iron homeostasis in chronicrespiratory failure. Int J Clin Pract. 2014;68(1):130–138.
   PubMed Web of Science ®Google Scholar
• Guo J, Zheng C, Xiao Q, et al. Impact of anaemia on lung function and exercise capacity in patients with stable severe chronic obstructive pulmonary disease. BMJ Open. 2015 Oct 8;5(10):e008295.
   PubMed Web of Science ®Google Scholar
• Copur AS, Fulambarker A, Molnar J, et al. Role of anemia in home oxygen therapy in chronic obstructive pulmonary disease patients. Am J Ther. 2015;22(5):361–366.
   PubMed Web of Science ®Google Scholar
• Ferrari M, Manea L, Anton K, et al. Anemia and hemoglobin serum levels are associated with exercise capacity and quality of life in chronic obstructive pulmonary disease. BMC Pulm Med. 2015;15(1):58.
   PubMedGoogle Scholar
• for the Keio COPD Comorbidity Research (K-CCR) Group, Haraguchi M, Nakamura H, Sasaki M, et al. Determinants of chronic obstructive pulmonary disease severity in the late-elderly differ from those in younger patients. BMC Res Notes. 2016;9(1):7.
   PubMedGoogle Scholar
• Koblizek V, Milenkovic B, Barczyk A, et al. Phenotypes of COPD patients with a smoking history in central and Eastern Europe: the POPE study. Eur Respir J. 2017;49(5):1601446.
   PubMed Web of Science ®Google Scholar
• Park SC, Kim YS, Kang YA, et al. Hemoglobin and mortality in patients with COPD: a nationwide population-based cohort study. Int J Chron Obstruct Pulmon Dis. 2018;13:1599–1605.
   PubMed Web of Science ®Google Scholar
• Oh YM, Park JH, Kim EK, et al. Anemia as a clinical marker of stable chronic obstructive pulmonary disease in the Korean obstructive lung disease cohort. J Thorac Dis. 2017;9(12):5008–5016.
   PubMed Web of Science ®Google Scholar
• Shorr AF, Doyle J, Stern L, et al. Anemia in chronic obstructive pulmonary disease: epidemiology and economic implications. Curr Med Res Opin. 2008;24(4):1123–1130.
   PubMed Web of Science ®Google Scholar
• Similowski T, Agustí A, MacNee W, et al. The potential impact of anaemia of chronic disease in COPD. Eur Respir J. 2006;27(2):390–396.
   PubMed Web of Science ®Google Scholar
• O’Sullivan ED, Hughes J, Ferenbach DA. Renal aging: causes and consequences. J Am Soc Nephrol. 2016;28(2):407–420.
   PubMed Web of Science ®Google Scholar
• Gaddam S, Gunukula SK, Lohr JW, et al. Prevalence of chronic kidney disease in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. BMC Pulm Med. 2016;16(1):158.
   PubMedGoogle Scholar
• Hillas G, Perlikos F, Tsiligianni I, et al. Managing comorbidities in COPD. Int J COPD. 2015;10:95–109.
   Google Scholar
• Ble A, Fink JC, Woodman RC, et al. Renal function, erythropoietin, and anemia of older persons: the InCHIANTI study. Arch Intern Med. 2005;165(19):2222–2227.
   PubMedGoogle Scholar
• Chiang C-K, Tanaka T, Inagi R, et al. Indoxyl sulfate, a representative uremic toxin, suppresses erythropoietin production in a HIF-dependent manner. Lab Invest. 2011;91(11):1564–1571.
   PubMed Web of Science ®Google Scholar
• Curkendall SM, DeLuise C, and Jones JK, et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol. 2006;16(1):63–70.
   PubMed Web of Science ®Google Scholar
• Le Jemtel TH, Padeletti M, Jelic S. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. J Am Coll Cardiol. 2007;49(2):171–180.
   PubMed Web of Science ®Google Scholar
• Groenveld HF, Januzzi JL, Damman K, et al. Anemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol. 2008;52(10):818–827.
   PubMed Web of Science ®Google Scholar
• Adams KF Jr Jr, Patterson JH, and Oren RM, et al. for STAMINA-HFP registry investigators. Prospective assessment of the occurrence of anemia in patients with heart failure: results from the study of anemia in a heart failure population. Am Heart J. 2009;157(5):926–932.
   PubMed Web of Science ®Google Scholar
• Iversen PO, Woldbaek PR, Tonnessen T, et al. Decreased hematopoiesis in bone marrow of mice with congestive heart failure. Am J Physiol. 2002;282:R166–R172.
   Google Scholar
• King PT. Inflammation in chronic obstructive pulmonary disease and its role in cardiovascular disease and lung cancer. Clin Transl Med. 2015;4(1):68.
   PubMedGoogle Scholar
• Jankowska EA, Malyszko J, Ardehali H, et al. Iron status in patients with chronic heart failure. Eur Heart J. 2013;34(11):827–834.
   PubMed Web of Science ®Google Scholar
• Mumby S, Adcock IM, Chung K, et al. Serum hepcidin levels are elevated in COPD and are associated with increased intracellular iron in the lung. Am J Respir Crit Care Med. 2012;185:A6769.
   Google Scholar
• Cloonan SM, Mumby S, Adcock IM, et al. The “iron”-y of iron overload and iron deficiency in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017;196(9):1103–1112.
   PubMed Web of Science ®Google Scholar
• Barberan-Garcia A, Rodríguez DA, Blanco I, et al. Non-anaemic iron deficiency impairs response to pulmonary rehabilitation in COPD. Respirology. 2015;20(7):1089–1095.
   PubMed Web of Science ®Google Scholar
• McDonald CF. Oxygen therapy for COPD. J Thorac Dis. 2014;6(11):1632–1639.
   PubMed Web of Science ®Google Scholar
• McMullin MF, Bareford D, Campbell P, et al. Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis. Br J Haematol. 2005;130(2):174–195.
   PubMed Web of Science ®Google Scholar
• Vlahakos DV, Kosmas EN, Dimopoulou I, et al. Association between activation of the renin-angiotensin system and secondary erythrocytosis in patients with chronic obstructive pulmonary disease. Am J Med. 1999;106(2):158–164.
   PubMed Web of Science ®Google Scholar
• Takayuki Iriyama T, Wang W, Parchim NF, et al. Hypoxia-independent up-regulation of placental HIF-1α gene expression contributes to the pathogenesis of preeclampsia. Hypertension. 2015;65(6):1307–1315.
   PubMed Web of Science ®Google Scholar
• Gossmann J, Burkhardt R, Harder S, et al. Angiotensin II infusion increases plasma erythropoietin levels via an angiotensin II type 1 receptor-dependent pathway. Kidney Int. 2001;60(1):83–86.
   PubMed Web of Science ®Google Scholar
• Mrug M, Stopka T, Julian BA, et al. Angiotensin II stimulates proliferation of normal early erythroid progenitors. J Clin Invest. 1997;100(9):2310–2314.
   PubMed Web of Science ®Google Scholar
• Ishizaka N, Saito K, Noiri E, et al. Administration of angiotensin II induces iron deposition and upregulation of TGF-β mRNA in the rat liver. Am J Physiol Regul Integr Comp Physiol. 2005;288(4):R1063–70.
   PubMed Web of Science ®Google Scholar
• Tajima S, Ikeda Y, Enomoto H, et al. Angiotensin II alters the expression of duodenal iron transporters, hepatic hepcidin, and body iron distribution in mice. Eur J Nutr. 2015;54(5):709–719.
   PubMed Web of Science ®Google Scholar
• Vlahakos DV, Marathias KP, Madias NE. The role of the renin-angiotensin system in the regulation of erythropoiesis. Am J Kidney Dis. 2010;56(3):558–565.
   PubMed Web of Science ®Google Scholar
• Vlahakos DV, Marathias KP, Agroyannis B, et al. Posttransplant erythrocytosis. Kidney Int. 2003;63(4):1187–1194.
   PubMed Web of Science ®Google Scholar
• Plata R, Cornejo A, Arratia C, et al. Angiotensin-converting-enzyme inhibition therapy in altitude polycythaemia: a prospective randomised trial. Lancet. 2002;359(9307):663–666.
   PubMed Web of Science ®Google Scholar
• Vlahakos DV, Marathias KP, Kosmas EN. Losartan reduces hematocrit in patients with chronic obstructive pulmonary disease and secondary erythrocytosis. Ann Intern Med. 2001;134(5):426–427.
   PubMed Web of Science ®Google Scholar
• Andreas S, Herrmann-Lingen C, Raupach T, et al. Angiotensin II blockers in obstructive pulmonary disease: a randomised controlled trial. Eur Respir J. 2006;27(5):972–979.
   PubMed Web of Science ®Google Scholar
• Nickol AH, Frise MC, Cheng HY, et al. A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease. BMJ Open. 2015;5(7):e007911.
   PubMed Web of Science ®Google Scholar
• Haja Mydin H, Murphy S, Clague H, et al. Anemia and performance status as prognostic markers in acute hyper-capnic respiratory failure due to chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2013;8:151–157.
   PubMed Web of Science ®Google Scholar
• Rasmussen L, Christensen S, Lenler-Petersen P, et al. Anemia and 90-day mortality in COPD patients requiring invasive mechanical ventilation. Clin Epidemiol. 2011;3(Suppl 1):1–5.
   PubMedGoogle Scholar
• Barba R, de Casasola GG, Marco J, et al. Anemia in chronic obstructive pulmonary disease: a readmission prognosis factor. Curr Med Res Opin. 2012;28(4):617–622.
   PubMed Web of Science ®Google Scholar
• Schonhofer B, Bohrer H, Kohler D. Blood transfusion facilitating difficult weaning from the ventilator. Anesthesia. 1998;53(2):181–184.
   PubMed Web of Science ®Google Scholar
• Singh AK, Szczech L, Tang KL, et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med. 2006;355(20):2085–2098.
   PubMed Web of Science ®Google Scholar
• Swedberg K, Young JB, Anand IS, et al. Treatment of anemia with darbepoetin Alfa in systolic heart failure. N Engl J Med. 2013;368(13):1210–1219.
   PubMed Web of Science ®Google Scholar
• Babitt, JL , Eisenga, MF , Haase , VH et al. Controversies in optimal anemia management: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) conference. Kidney Int. 2021;99(6):1280–1295.
   PubMed Web of Science ®Google Scholar
• Nickol AH, Frise MC, Cheng H-Y, et al. A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease. BMJ Open. 2015;5(7):e007911.
   PubMed Web of Science ®Google Scholar
• Plesner LL, Schoos MM, Dalsgaard M, et al. Iron deficiency in copd associates with increased pulmonary artery pressure estimated by echocardiography. Heart Lung Circ. 2017 Jan;26(1):101–104.
   PubMed Web of Science ®Google Scholar
• Patel MS, McKie E, Steiner MC, et al. Anaemia and iron dysregulation: untapped therapeutic targets in chronic lung disease? BMJ Open Respir Res. 2019Aug30;6(1):e000454. PMID:31548896; PMCID: PMC6733331.
   PubMed Web of Science ®Google Scholar
• Anker SD, Comin-Colet J, Filippatos G, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009;361(25):2436–2448.
   PubMed Web of Science ®Google Scholar
• Ponikowski P, van Veldhuisen DJ, Comin-Colet J, et al. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. Eur Heart J. 2015;36(11):657–668.
   PubMed Web of Science ®Google Scholar
• Gerards MC, Venema GE, Patberg KW, et al. Dapagliflozin for prednisone‐induced hyperglycaemia in acute exacerbation of chronic obstructive pulmonary disease. Diabetes Obes Metab. 2018 May;20(5):1306–1310.
   PubMed Web of Science ®Google Scholar
• Marathias KP, Lambadiari VA, Markakis KP, et al. Competing effects of renin angiotensin system blockade and sodium-glucose cotransporter-2 inhibitors on erythropoietin secretion in diabetes. Am J Nephrol. 2020;51(5):349–356.
   PubMed Web of Science ®Google Scholar
• Mazer CD, Hare GMT, Connelly PW, et al. Effect of empagliflozin on erythropoietin levels, iron stores, and red blood cell morphology in patients with type 2 diabetes mellitus and coronary artery disease. Circulation. 2020;141(8):704–707.
   PubMed Web of Science ®Google Scholar
• Das L, Bhansali A, Walia R. Unmasking and aggravation of polycythemia vera by canagliflozin. Diabet Med. 2018;35(11):1613–1616.
   PubMed Web of Science ®Google Scholar
• Motta G, Zavattaro M, Romeo F, et al. Risk of erythrocytosis during concomitant testosterone and SGLT2-Inhibitor treatment: a warning from two clinical cases. J Clin Endocrinol Metab. 2019;104(3):819–822.
   PubMed Web of Science ®Google Scholar
• Gupta R, Gupta A, Shrikhande M, et al. Marked erythrocytosis during treatment with sodium glucose cotransporter-2 inhibitors-report of two cases. Diabetes Res Clin Pract. 2020;162:108127.
   PubMed Web of Science ®Google Scholar